 Administration, Oral
"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 8 | 8 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 7 | 7 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 6 | 6 | | 2001 | 0 | 6 | 6 | | 2002 | 0 | 10 | 10 | | 2003 | 0 | 8 | 8 | | 2004 | 0 | 25 | 25 | | 2005 | 0 | 12 | 12 | | 2006 | 0 | 9 | 9 | | 2007 | 0 | 22 | 22 | | 2008 | 0 | 18 | 18 | | 2009 | 0 | 12 | 12 | | 2010 | 0 | 27 | 27 | | 2011 | 0 | 20 | 20 | | 2012 | 0 | 32 | 32 | | 2013 | 0 | 21 | 21 | | 2014 | 0 | 29 | 29 | | 2015 | 0 | 25 | 25 | | 2016 | 0 | 35 | 35 | | 2017 | 0 | 31 | 31 | | 2018 | 0 | 44 | 44 | | 2019 | 1 | 36 | 37 | | 2020 | 0 | 33 | 33 | | 2021 | 0 | 27 | 27 | | 2022 | 0 | 6 | 6 | | 2023 | 0 | 9 | 9 | | 2024 | 0 | 19 | 19 | | 2025 | 0 | 26 | 26 | | 2026 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
You L, Parikh HM, Triolo TM, Ferrat LA, Templeman EL, Oram RA, Gottlieb PA, Rich SS, Onengut-Gumuscu S, Steck AK, Krischer J, Redondo MJ. Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention. Diabetes Care. 2026 Feb 01; 49(2):344-351.
-
Moore CF, Bergeria CL, Sempio C, Klawitter J, Christians U, Weerts EM. High doses of orally administered cannabigerol produce deficits in sustained attention in female rats. Pharmacol Biochem Behav. 2026 Mar; 260:174154.
-
Shah MM, Abedi GR, Lu S, Garcia-Knight M, Pineda-Ramirez J, Goldberg SA, Grijalva CG, Keipp Talbot H, Schmitz J, Lutrick K, Ellingson KD, Stockwell MS, Sano E, Nguyen HQ, Rao S, Asturias EJ, Suthar MS, Mellis AM, Deeks SG, Martin JN, Peluso MJ, Andino R, Rolfes MA, Kirking HL, Smith-Jeffcoat SE, Midgley CM, Hagen MB, Kelly JD. SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies. Lancet Microbe. 2026 Jan; 7(1):101227.
-
Lehenbauer KS, Nelson AJ, Nodari S, Sverdlov AL, Harrington J. The impact of oral semaglutide on cardiovascular events in patients with type 2 diabetes: review of results from the SOUL trial. Heart Fail Rev. 2025 Dec 10; 31(1):11.
-
Shimano KA, Grimes AB, Kaicker S, Shah SJ, Gunn E, Bhat RV, Kochhar M, Rothman JA, Rose MJ, Briones M, Nakano TA, Lebensburger JD, Lambert MP, Fritch Lilla SA, Jesudas R, Lee-Miller CA, Thompson AA, Rifkin-Zenenberg S, Majumdar S, Crary SE, Hege K, Ford JB, Bies JJ, Fort J, Wynn TT, Hsieh L, Ruiz ME, Dinu B, Wong JMW, Kao PC, Kim TO, Arnold SD, Bennett CM, Despotovic JM, Klaassen RJ, Neufeld EJ, Neunert CE, London WB, Grace RF. Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial. JAMA. 2025 11 25; 334(20):1816-1826.
-
Solo KJ, Zhang Y, Bharathi SS, Zhang BB, Richert AC, Schmidt AV, Van't Land C, D'Annibale O, Wood TC, Goetzman ES. Oral octanoylcarnitine alleviates exercise intolerance in mouse models of long-chain fatty acid oxidation disorders. JCI Insight. 2025 Nov 24; 10(22).
-
Haynes AS, Wei Z, Scheetz MH, Gonzalez D, Messacar K, Tang Girdwood S, Peloquin CA, Fish DN, Anderson P. Oral Cephalexin Population Pharmacokinetics and Target Attainment Analysis in Infants 7-60 Days Old. J Pediatric Infect Dis Soc. 2025 Oct 02; 14(10).
-
Singh S, Singh AK, Singh AN, Singh SK, Yadav VB, Gangwar M, Sahu M, Kumar D, Nath G. Efficacy of bacteriophage cocktails administered through mucosal and non-mucosal routes for urinary tract infections caused by Enterobacter cloacae: A preclinical study. Microb Pathog. 2025 Dec; 209:108024.
-
Brooks Peterson M, Boyd J, Zhu A, Bothwell S, Prager JD. Seeking a Viable Alternative: A Prospective, Randomized, Controlled, Double-Blind Non-Inferiority Study of Oral Versus IV Dexamethasone in Children Undergoing Tonsillectomy. Paediatr Anaesth. 2025 Nov; 35(11):953-961.
-
Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 Nov; 248:108340.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|